Cite

HARVARD Citation

    Yoshino, T. et al. (n.d.). 563PUpdated results of phase I study of trastuzumab deruxtecan (DS-8201a) in HER2-expressing advanced colorectal cancer. Annals of oncology. p. . [Online]. 
  
Back to record